Kelei Du
Melbourne Immunotherapy Network Winter Retreat 2018
Days
Friday, 31st August
Saturday, 1st September
Search
Speakers
Kelei Du
Abstracts this author is presenting:
Manipulation of recipient NK cells using Ruxolitinib to target the IL-15 signaling pathway improves allo-HSCT outcomes.
—
Welcome Function and Poster Session